Man Group PLC Alector, Inc. Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Alector, Inc. stock. As of the latest transaction made, Man Group PLC holds 67,537 shares of ALEC stock, worth $374,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,537

Previous 65,298 3.43%

Holding current value

$374,830

Previous $393,000 22.14%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.19 - $6.23 $9,381 - $13,948	2,239 Added 3.43%	67,537 $306,000
Q1 2024 May 15, 2024	BUY	$5.69 - $8.08 $308,022 - $437,402	54,134 Added 484.9%	65,298 $393,000
Q4 2023 Feb 14, 2024	SELL	$3.77 - $8.39 $207,063 - $460,812	-54,924 Reduced 83.11%	11,164 $89,000
Q3 2023 Nov 14, 2023	SELL	$5.2 - $8.77 $236,017 - $398,052	-45,388 Reduced 40.72%	66,088 $428,000
Q2 2023 Aug 14, 2023	SELL	$5.86 - $7.93 $1.12 Million - $1.52 Million	-191,318 Reduced 63.18%	111,476 $669,000
Q1 2023 May 15, 2023	BUY	$5.85 - $9.84 $629,161 - $1.06 Million	107,549 Added 55.08%	302,794 $1.87 Million
Q4 2022 Feb 14, 2023	BUY	$6.88 - $9.55 $850,484 - $1.18 Million	123,617 Added 172.58%	195,245 $1.8 Million
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $438,795 - $707,216	53,577 Added 296.81%	71,628 $678,000
Q2 2022 Aug 15, 2022	BUY	$7.65 - $14.24 $138,090 - $257,046	18,051 New	18,051 $183,000
Q1 2021 May 17, 2021	SELL	$14.84 - $22.23 $1.14 Million - $1.71 Million	-76,919 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.4 - $16.7 $723,038 - $1.28 Million	76,919 New	76,919 $1.16 Million
Q3 2020 Nov 16, 2020	SELL	$10.54 - $24.96 $2.23 Million - $5.28 Million	-211,678 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$21.87 - $33.11 $4.63 Million - $7.01 Million	211,678 New	211,678 $5.17 Million

Others Institutions Holding ALEC

# of Institutions

167

Shares Held

58.4M

Call Options Held

57K

Put Options Held

14.9K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $458M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account